Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Sarcoma 1Pancreatic Neoplasms 1Osteosarcoma 1Mesothelioma, Malignant 1Lung Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Granulocyte Colony-Stimulating Factor 3Filgrastim 3belinostat 2Topotecan 2Cyclophosphamide 2Carboplatin 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1entinostat 1cixutumumab 1alvocidib 1alanosine 1abemaciclib 1Thrombopoietin 1Thiotepa 1Thalidomide 1Sirolimus 1Simvastatin 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1LY2940680 1Immunotherapy 1Immunologic Techniques 1Imatinib Mesylate 1Ifosfamide 1Fluorouracil 1Fentanyl 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × alanosine × Other solid neoplasm × Clear all
NCT00062283 2013-06-26

Alanosine in Treating Patients With Cancer

National Cancer Institute (NCI)

Phase 2 Completed
GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡